These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 27999206)
1. Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis. Xu F; Li M; Zhang C; Cui J; Liu J; Li J; Jiang H Oncotarget; 2017 Jan; 8(4):6003-6012. PubMed ID: 27999206 [TBL] [Abstract][Full Text] [Related]
2. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients. Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800 [TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression]. Fan Y; Guan Y; Zhao WH; Li Q; Xu BH Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis. Jiang D; Gao Z; Cai Z; Wang M; He J BMC Cancer; 2015 Oct; 15():727. PubMed ID: 26475790 [TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis. Qiao W; Liu H; Guo W; Li P; Deng M Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194 [TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis. Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients. Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286 [TBL] [Abstract][Full Text] [Related]
8. The importance of COX-2 expression as prognostic factor in early breast cancer. Kargi A; Uysal M; Bozcuk H; Coskun HS; Savas B; Ozdogan M J BUON; 2013; 18(3):579-84. PubMed ID: 24065467 [TBL] [Abstract][Full Text] [Related]
9. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer. Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis. Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505 [TBL] [Abstract][Full Text] [Related]
11. A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients. Miglietta L; Morabito F; Provinciali N; Canobbio L; Meszaros P; Naso C; Murialdo R; Boitano M; Salvi S; Ferrarini M Eur J Surg Oncol; 2013 Oct; 39(10):1046-52. PubMed ID: 23890870 [TBL] [Abstract][Full Text] [Related]
12. Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status. Murphy NC; Biankin AV; Millar EK; McNeil CM; O'Toole SA; Segara D; Crea P; Olayioye MA; Lee CS; Fox SB; Morey AL; Christie M; Musgrove EA; Daly RJ; Lindeman GJ; Henshall SM; Visvader JE; Sutherland RL Int J Cancer; 2010 Mar; 126(6):1445-53. PubMed ID: 19676041 [TBL] [Abstract][Full Text] [Related]
13. Clinical Implications of TβRII Expression in Breast Cancer. Gao N; Zhai Q; Li Y; Huang K; Bian D; Wang X; Liu C; Xu H; Zhang T PLoS One; 2015; 10(11):e0141412. PubMed ID: 26551005 [TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion]. Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy]. Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696 [TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis. Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103 [TBL] [Abstract][Full Text] [Related]
17. Hormonal Receptor, Human Epidermal Growth Factor and Its Association with Breast Cancer Tumor Characteristics in Albania. Pajenga E; Rexha T; Çeliku S; Ugrinska A; Bejtja G Cent Eur J Public Health; 2016 Sep; 24(3):171-175. PubMed ID: 27760283 [TBL] [Abstract][Full Text] [Related]
18. Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma. El-Gendi SM; Mostafa MF Pathol Oncol Res; 2016 Jul; 22(3):461-70. PubMed ID: 26597806 [TBL] [Abstract][Full Text] [Related]
19. HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients. Bae SY; La Choi Y; Kim S; Kim M; Kim J; Jung SP; Choi MY; Lee SK; Kil WH; Lee JE; Nam SJ Breast Cancer Res Treat; 2013 Jun; 139(3):741-50. PubMed ID: 23722313 [TBL] [Abstract][Full Text] [Related]
20. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]